Cargando…
Developing BET-ter treatments for cutaneous T-cell lymphoma
Autor principal: | Wong, Henry K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407685/ https://www.ncbi.nlm.nih.gov/pubmed/30863486 http://dx.doi.org/10.18632/oncotarget.26662 |
Ejemplares similares
-
BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014) -
Problems that Physicians should Notice for Bet ter Treatment of Hypercholesterolemia in Japan
por: Fujioka, Yoshio
Publicado: (2019) -
Regulating BETs at central station
por: Dawson, Mark A.
Publicado: (2015) -
Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphoma
por: Patrone, Christina Chung, et al.
Publicado: (2019) -
T-bet in Tfh cells: Now you see me, now you don’t
por: Kaech, Susan M.
Publicado: (2018)